Avanos Medical
AVNS
AVNS was delisted on the 24th of July, 2026.
260 hedge funds and large institutions have $1.03B invested in Avanos Medical in 2024 Q3 according to their latest regulatory filings, with 37 funds opening new positions, 63 increasing their positions, 77 reducing their positions, and 33 closing their positions.
22% more capital invested
Capital invested by funds: $843M → $1.03B (+$188M)
12% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 33
1.18% more ownership
Funds ownership: 92.15% → 93.33% (+1.2%)
1% more funds holding
Funds holding: 258 → 260 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less call options, than puts
Call options by funds: $149K | Put options by funds: $163K
18% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 77
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$17.7M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$8.18M |
| 3 |
Goldman Sachs
New York
|
+$5.5M |
| 4 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
+$3.73M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$3.41M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$4.32M |
| 2 |
D.E. Shaw & Co
New York
|
-$3.22M |
| 3 |
EF
Empowered Funds
Havertown,
Pennsylvania
|
-$2.91M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.71M |
| 5 |
TCM
Tributary Capital Management
Omaha,
Nebraska
|
-$2.2M |
AVNS Hedge Fund Activity: Q3 2024 in Review
260 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q3 2024, worth a combined $1.03B — up 22% from $843M a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new AVNS positions and 33 closed out — a net gain of 4 holders — while 63 added to existing stakes and 77 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $17.7M. The largest seller was Bridgeway Capital Management, cutting an estimated $4.32M.
- 260 institutional investors held Avanos Medical (AVNS) as of Q3 2024, up from 258 in Q2 2024.
- Funds reported $1.03B of Avanos Medical stock for Q3 2024, up 22% quarter-over-quarter.
- 37 funds opened new Avanos Medical positions in Q3 2024 and 33 closed out, a net change of +4 holders.
- The largest Avanos Medical buyer in Q3 2024 was Morgan Stanley, an estimated $17.7M added.
- The largest Avanos Medical seller in Q3 2024 was Bridgeway Capital Management, an estimated $4.32M sold.
Based on aggregated 13F filings for Q3 2024.